Astria Therapeutics, Inc. (ATXS)
ATXS Stock Price Chart
Explore Astria Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ATXS price movements and trends.
ATXS Company Profile
Discover essential business fundamentals and corporate details for Astria Therapeutics, Inc. (ATXS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 Jun 2015
Employees
78.00
Website
https://www.astriatx.comCEO
Jill C. Milne
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.
ATXS Financial Timeline
Browse a chronological timeline of Astria Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 12 Nov 2025
EPS estimate is -$0.42.
Earnings released on 12 Aug 2025
EPS came in at -$0.57 surpassing the estimated -$0.61 by +6.56%.
Earnings released on 13 May 2025
EPS came in at -$0.58 falling short of the estimated -$0.48 by -20.83%.
Earnings released on 11 Mar 2025
EPS came in at -$0.44 surpassing the estimated -$0.45 by +2.22%.
Earnings released on 13 Nov 2024
EPS came in at -$0.42 matching the estimated -$0.42.
Earnings released on 12 Aug 2024
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%.
Earnings released on 9 May 2024
EPS came in at -$0.38 falling short of the estimated -$0.35 by -8.57%.
Earnings released on 4 Mar 2024
EPS came in at -$0.86 falling short of the estimated -$0.69 by -24.64%.
Earnings released on 13 Nov 2023
EPS came in at -$0.63 falling short of the estimated -$0.51 by -23.53%.
Earnings released on 7 Aug 2023
EPS came in at -$0.45 surpassing the estimated -$0.50 by +10.00%.
Earnings released on 11 May 2023
EPS came in at -$0.40 surpassing the estimated -$0.51 by +21.57%.
Earnings released on 22 Mar 2023
EPS came in at -$0.72 surpassing the estimated -$0.74 by +2.70%.
Earnings released on 10 Nov 2022
EPS came in at -$0.87 surpassing the estimated -$0.92 by +5.43%.
Earnings released on 9 Aug 2022
EPS came in at -$0.86 surpassing the estimated -$1.04 by +17.31%.
Earnings released on 12 May 2022
EPS came in at -$1.18 falling short of the estimated -$0.73 by -61.64%.
Earnings released on 10 Mar 2022
EPS came in at -$0.73 falling short of the estimated -$0.61 by -19.67%.
Earnings released on 10 Nov 2021
EPS came in at -$0.61 surpassing the estimated -$0.92 by +33.70%.
Stock split effective on 20 Aug 2021
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Aug 2021
EPS came in at -$1.26 surpassing the estimated -$1.82 by +30.77%.
Earnings released on 13 May 2021
EPS came in at -$1.44 falling short of the estimated -$0.92 by -56.52%.
Earnings released on 11 Mar 2021
EPS came in at -$2.64 falling short of the estimated -$2.22 by -18.92%.
Earnings released on 12 Nov 2020
EPS came in at -$3.36 falling short of the estimated -$3.06 by -9.80%.
ATXS Stock Performance
Access detailed ATXS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.